Soluble Receptor for Advanced Glycation End Products (sRAGE) is decreased in patients with Juvenile Idiopathic Arthritis (ERA category) and inversely correlates with disease activity and S100A12 levels

Detalles Bibliográficos
Autores principales: Aggarwal, Amita, Myles, Arpita, Viswanath, Vishad, Singh, Yogesh Preet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194534/
http://dx.doi.org/10.1186/1546-0096-9-S1-P179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194534/
http://dx.doi.org/10.1186/1546-0096-9-S1-P179

Ejemplares similares